EarningsQ4 2024 Earnings Report

BioMarin Pharmaceutical (BMRN) Q4 2024 Earnings Report

0 Followers

MX:BMRN Q4 2024 EPS Results

Actual EPS$11.50

Consensus EPS$9.59

Beat/MissBeat by +$1.90

One Year Ago EPS$1.98

Actual Revenue$13.26B

Expected Revenue$12.79B

Beat/MissBeat by +$465.66M

YoY Revenue Growth+14.29%

QuarterQ4 2024

Date02/19/2025

TimeAfter Close

Conference CallWednesday, February 19, 2025

MX:BMRN Upcoming Earnings

BioMarin Pharmaceutical's next earnings date is estimated for November 3, 2026, based on past reporting schedules.

MX:BMRN Q4 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 03, 2026	2026 (Q3)	23.98 / -	-2.874	―
Aug 06, 2026	2026 (Q2)	17.01 / 21.55	22.094	-2.44% (-0.54)
May 04, 2026	2026 (Q1)	12.43 / 13.65	17.064	-20.00% (-3.41)
Feb 23, 2026	2025 (Q4)	3.04 / -4.31	11.496	-137.50% (-15.81)
Oct 27, 2025	2025 (Q3)	-5.03 / -2.87	9.879	-129.09% (-12.75)
Aug 04, 2025	2025 (Q2)	15.47 / 22.09	9.879	123.64% (+12.21)
May 01, 2025	2025 (Q1)	12.83 / 17.06	8.263	106.52% (+8.80)
Feb 19, 2025	2024 (Q4)	9.59 / 11.50	1.976	481.82% (+9.52)
Oct 29, 2024	2024 (Q3)	9.54 / 9.88	3.772	161.90% (+6.11)
Aug 05, 2024	2024 (Q2)	6.43 / 9.88	5.209	89.66% (+4.67)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed